DE ANGELIS, CLAUDIA
DE ANGELIS, CLAUDIA
Medicina Sperimentale e Clinica
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer
2025 Catalano, Martina; Cekrezi, Gestiana; De Gennaro Aquino, Irene; Ravizza, Delia; Paulet, Alexandra; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer
2025 Tubita, Alessandro; De Angelis, Claudia; Grasso, Daniela; Sorbi, Flavia; Castiglione, Francesca; Anela, Lorenzo; Petrella, Maria Cristina; Fambrini, Massimiliano; Scolari, Federico; Bernini, Andrea; Petroni, Giulia; Pillozzi, Serena; Antonuzzo, Lorenzo
The good, the bad, and the manageable: real-world outcomes with CDK4/6 inhibitors
2026 Paulet, Alexandra; Mancini, Silvia; Catalano, Martina; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer | 2025 | Catalano, Martina; Cekrezi, Gestiana; De Gennaro Aquino, Irene; Ravizza, Delia; Paulet, Alexandra; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico | |
| Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer | 2025 | Tubita, Alessandro; De Angelis, Claudia; Grasso, Daniela; Sorbi, Flavia; Castiglione, Francesca; Anela, Lorenzo; Petrella, Maria Cristina; Fambrini, Massimiliano; Scolari, Federico; Bernini, Andrea; Petroni, Giulia; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| The good, the bad, and the manageable: real-world outcomes with CDK4/6 inhibitors | 2026 | Paulet, Alexandra; Mancini, Silvia; Catalano, Martina; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico |